Genetic basis of glioma progression

Proceedings of the Japan Academy Series B: Physical and Biological Sciences

Volumn 79, Issue 3, 2003, Pages 78-85

  Ohgaki, Hiroko ^a   Kleihues, Paul ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

EGFR; Genetic pathway; Glioblastoma; MGMT; SV40; TP53

Indexed keywords

SIMIAE; SIMIAN VIRUS 40;

EID: 0037525200     PISSN: 03862208     EISSN: None     Source Type: Journal    
DOI: 10.2183/pjab.79B.78     Document Type: Review

References (76)

1. Watanabe, K , Tachibana, O., Sato, K., Yonekawa, Y., Kleihues, P , and Ohgaki, H. (1996) Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol. 6, 217-224.
2. Biernat, W., Kleihues, P., Yonekawa, Y., and Ohgaki, H (1997) Amplification and overexpression of MDM2 in primary (de novo) glioblastomas. J. Neuropathol. Exp. Neurol. 56, 180-185.
3. Biernat, W., Tohma, Y., Yonekawa, Y., Kleihues, P., and Ohgaki, H. (1997) Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas. Acta Neuropathol. 94, 303-309.
4. Tohma, Y., Gratas, C., Biernat, W., Peraud, A., Fukuda, M., Yonekawa, Y., Kleihues, P., and Ohgaki, H. (1998) PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J. Neuropathol Exp. Neurol. 57, 684-689.
5. Fujisawa, H., Reis, R. M., Nakamura, M., Colella, S., Yonekawa, Y., Kleihues, P., and Ohgaki, H. (2000) Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas. Lab. Invest. 80, 65-72
6. Nakamura, M., Yang, F., Fujisawa, H., Yonekawa, Y , Kleihues, P , and Ohgaki, H. (2000) Loss of heterozygosity on chromosome 19 in secondary glioblastomas. J. Neuropathol. Exp. Neurol 59, 539-543.
7. Arf deletion and methylation in genetic pathways to glioblastomas. Brain Pathol. 11, 159-168
8. Nakamura, M., Yonekawa, Y., Kleihues, P., and Ohgaki, H. (2001) Promoter hypermethylation of the RB1 gene in glioblastomas Lab Invest 81, 77-82.
9. Nakamura, M., Watanabe, T., Yonekawa, Y , Kleihues, P., and Ohgaki, H (2001) Promoter hypermethylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G·:C→A·T mutations of the TP53 tumor suppressor gene. Carcinogenesis 22, 1715-1719.
10. 1-phase progression. Genes Dev 13, 1501-1512.
11. ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17, 5001-5014.
12. Zhang, Y., Xiong, Y., and Yarbrough, W. G. (1998) ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 92, 725-734.
13. Watanabe, K., Sato, K., Biernat, W , Tachibana, O , von Ammon, K., Ogata, N., Yonekawa, Y., Kleihues, P., and Ohgaki, H. (1997) Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies Clin Cancer Res. 3, 523-530.
14. Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E. E., and Collins, V. P. (1993) Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res. 53, 2736-2739.
15. Rasheed, B. K., Wiltshire, R. N., Bigner, S. H., and Bigner, D. D. (1999) Molecular pathogenesis of malignant gliomas. Curr. Opin. Oncol. 11, 162-167
16. Wikstrand, C. J., Reist, C. J., Archer, G. E., Zalutsky, M. R., and Bigner, D. D. (1998) The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target. J. Neurovirol. 4, 148-158
17. Kuan, C. T., Wikstrand, C. J., and Bigner, D. D. (2000) EGFRvIII as a promising target for antibody-based brain tumor therapy. Brain Tumor Pathol 17, 71-78
18. Sugawa, N., Ekstrand, A J., James C. D , and Collins, V P. (1990) Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas Proc Natl Acad. Sci. U. S. A. 87, 8602-8606.
19. Schwechheimer, K , Huang, S., and Cavenee, W. K. (1995) EGFR gene amplification-rearrangement in human glioblastomas. Int. J. Cancer 62, 145-148.
20. Worm, K., Dabbagh, P., and Schwechheimer, K (1999) Reverse transcriptase polymerase chain reaction as a reliable method to detect epidermal growth factor receptor exon 2-7 gene deletion in human glioblastomas. Hum. Pathol. 30, 222-227.
21. Rasheed, B. K , McLendon, R E., Friedman, H S., Friedman, A. H., Fuchs, H E , Bigner, D. D., and Bigner, S H. (1995) Chromosome 10 deletion mapping in human gliomas. a common deletion region in 10q25. Oncogene 10, 2243-2246.
22. Albarosa, R., Colombo, B. M., Roz, L., Magnani, I., Pollo, B , Cirenei, N., Giani, C., Conti, A. M. F., DiDonato, S., and Finocchiaro, G. (1996) Deletion mapping of gliomas suggests the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q. Am. J. Hum. Genet. 58, 1260-1267
23. Voesten, A. M. J., Bijleveld, E. H., Westerveld, A , and Hulsebos, T. J. M (1997) Fine mapping of a region of common deletion on chromosome arm 10p in human glioma. Genes Chromosomes Cancer 20, 167-172.
24. Fults, D., Pedone, C. A., Thompson, G. E., Uchiyama, C M., Gumpper, K. L., Iliev, D., Vinson, V. L., Tavtigian, S. V., and Perry, W. L., III (1998) Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme. Int J. Oncol. 12, 905-910.
25. Ichimura, K., Schmidt, E. E , Miyakawa, A , Goike, H. M., and Collins, V. P (1998) Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades. Genes Chromosomes Cancer 22, 9-15.
26. Karlbom, A. E., James, C. D., Boethius, J., Cavenee, W. K , Collins, V. P , Nordenskjold, M., and Larsson, C. (1993) Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum. Genet. 92, 169-174.
27. von Deimling, A., von Ammon, K , Schoenfeld, D , Wiestler, O. D., Seizinger, B. R., and Louis, D. N. (1993) Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol. 3, 19-26.
28. Maier, D., Zhang, Z., Taylor, E., Hamou, M. F., Gratzl, O , Van Meir, E. G., Scott, R. J., and Merlo, A. (1998) Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas. Oncogene 16, 3331-3335.
29. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S. H., Giovanella, B. C., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M. H., and Parsons, R. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947
30. Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W K., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D H. F., and Tavtigian, S. V. (1997) Identification of a candidate tumor suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 15, 356-362.
31. Fujisawa, H , Kurrer, M., Reis, R. M., Yonekawa, Y., Kleihues, P., and Ohgaki, H. (1999) Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with LOH on chromosome 10q25-qter Am. J Pathol. 155, 387-394.
32. Huang, H , Colella, S., Kurrer, M., Yonekawa, Y., Kleihues, P., and Ohgaki, H (2000) Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays. Cancer Res. 60, 6868-6874.
33. Sallinen, S. L., Sallinen, P. K., Haapasalo, H. K , Helin, H. J., Helen, P. T., Schraml, P., Kallioniemi, O P., and Kononen, J. (2000) Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res. 60, 6617-6622.
34. Ljubimova, J. Y., Lakhter, A. J , Loksh, A., Yong, W. H , Riedinger, M. S., Miner, J. H , Sorokin, L. M., Ljubimov, A. V., and Black, K. L (2001) Overexpression of α4 chain-containing laminins in human glial tumors identified by gene microarray analysis Cancer Res. 61, 5601-5610.
35. Hui, A. B , Lo, K. W , Yin, X. L., Poon, W. S., and Ng, H K. (2001) Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization. Lab. Invest. 81, 717-723.
36. Brustle, O , Ohgaki, H , Schmitt, H. P., Walter, G. F., Ostertag, H., and Kleihues, P. (1992) Primitive neuroectodermal tumors after prophylactic central nervous system irradiation in children. Association with an activated K-ras gene. Cancer 69, 2385-2392
37. Li, F. P , and Fraumeni, J. F., Jr. (1969) Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann. Intern Med 71, 747-752.
38. Li, F P., Fraumeni, J F., Jr., Mulvihill, J J , Blattner, W. A., Dreyfus, M. G., Tucker, M. A., and Miller, R. W. (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res. 48, 5358-5362.
39. Kleihues, P , Schauble, B., zur Hausen, A., Esteve, J , and Ohgaki, H. (1997) Tumors associated with p53 germline mutations: a synopsis of 91 families. Am. J. Pathol. 150, 1-13.
40. Malkin, D., Li, F. P., Strong, L C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bishoff, F. Z , and Tainsky, M. A. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233-1238.
41. Srivastava, S , Zou, Z. Q., Pirollo, K., Blattner, W. A , and Chang, E. H (1990) Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome Nature 348, 747-749
42. Ohgaki, H., Vital, A , Kleihues, P., and Hainaut, P. (2000) Li-Fraumeni syndrome and TP53 germline mutations. In WHO classification of tumors. Pathology and Genetics of Tumors of the Nervous System (eds. Kleihues, P., and Cavenee, W. K.). IARC Press, Lyon, pp. 231-234
43. Kleihues, P , Schauble, B., zur Hausen, A., Esteve, J., and Ohgaki, H. (1997) Tumors associated with p53 germline mutations Am. J. Pathol 150, 1-13.
44. Malkin, D. (1994) p53 and the Li-Fraumeni syndrome. Biochim. Biophys. Acta 1198, 197-213.
45. Cavenee, W. K., Burger, P. C., and Van Meir, E G. (2000) Turcot syndrome. In WHO classification of tumors: Pathology and Genetics of Tumors of the Nervous System (eds. Kleihues, P., and Cavenee, W K.) IARC Press, Lyon, pp. 238-239.
46. von Deimling, A., Foster, R., and Krone, W (2000) Neurofibromatosis type 1 In WHO classification of tumors: Pathology and Genetics of Tumors of the Nervous System (eds. Kleihues, P., and Cavenee, W. K.). IARC Press, Lyon, pp 216-218.
47. Louis, D. N , Stemmer-Rachamimov, A O., and Wiestler, O D. (2000) Neurofibromatosis type 2. In WHO classification of tumors Pathology and Genetics of Tumors of the Nervous System (eds. Kleihues, P., and Cavenee, W. K.). IARC Press, Lyon, pp. 219-222.
48. Palmiter, R. D., Chen, H. Y , Messing, A., and Brinster, R. L (1985) SV40 enhancer and large-T antigen are instrumental in development of choroid plexus tumors in transgenic mice. Nature 316, 457-460.
49. Eibl, R. H., Kleihues, P., Jat, P. S., and Wiestler, O. D (1994) A model for primitive neuroectodermal tumors in transgenic neural transplants harboring the SV40 large T antigen. Am. J. Pathol. 144, 556-564.
50. Kleihues, P., Wiestler, O. D., Ohgaki, H., and Aguzzi, A. (1998) Animal models of tumors of the nervous system. In The Gliomas (eds. Berger, M., and Wilson, Ch.). W B. Saunders, Cambridge, MA, pp. 124-133.
51. Barbanti-Brodano, G., Martini, F., De Mattei, M., Lazzarin, L., Corallini, A., and Tognon, M. (1998) BK and JC human polyomaviruses and Simian virus 40: natural history of infection in humans, experimental oncogenicity, and association with human tumors Adv Virus Res 50, 69-99.
52. Carbone, M., Rizzo, P., and Pass, H. I. (1997) Simian virus 40, poliovaccines and human tumors: a review of recent developments. Oncogene 15, 1877-1888.
53. Walsh, J. W., Zimmer, S. G., and Perdue, M. L (1982) Role of viruses in the induction of primary intracranial tumors. Neurosurgery 10, 643-662.
54. Ray, F. A , Peabody, D S., Cooper, J. L., Cram, L. S., and Kraemer, P. M. (1990) SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts J. Cell Biochem. 42, 13-31.
55. Butel, J. S., and Lednicky, J. A (1999) Cell and molecular biology of simian virus 40: implications for human infections and disease. J. Natl. Cancer Inst. 91, 119-134.
56. Stewart, N., and Bacchetti, S. (1991) Expression of SV40 large T antigen, but not small t antigen, is required for the induction of chromosomal aberrations in transformed human cells. Virology 180, 49-57.
57. Huang, H., Reis, R., Yonekawa, Y., Lopes, J M., Kleihues, P., and Ohgaki, H. (1999) Identification in human brain tumors of DNA sequences specific for SV40 large T antigen. Brain Pathol 9, 33-44.
58. Martini, F., Iaccheri, L , Lazzarin, L., Carinci, P., Corallini, A., Gerosa, M., Iuzzolino, P., Barbanti-Brodano, G., and Tognon, M. (1996) SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res. 56, 4820-4825.
59. Strickler, H. D., Goedert, J. J., Fleming, M , Travis, W. D., Williams, A. E., Rabkin, C. S., Daniel, R. W., and Shah, K. V. (1996) Simian virus 40 and pleural mesothelioma in humans. Cancer Epidemiol. Biomarkers Prev. 5, 473-475.
60. Shah, K. V., Daniel, R. W., Strickler, H. D., and Goedert, J J. (1997) Investigation of human urine for genomic sequences of the primate polyomaviruses simian virus 40, BK virus, and JC virus J. Infect Dis. 176, 1618-1621.
61. Shah, K , and Nathanson, N. (1976) Human exposure to SV40 review and comment. Am. J. Epidemiol. 103, 1-12
62. Geissler, E. (1990) SV40 and human brain tumors Prog. Med. Virol 37, 211-222.
63. Pepper, C., Jasani, B , Navabi, H., Wynford-Thomas, D , and Gibbs, A. R. (1996) Simian virus 40 large T antigen (SV40LTAg) primer specific DNA amplification in human pleural mesothelioma tissue. Thorax 51, 1074-1076.
64. Melnick, J. L., and Stinebaugh, S. (1962) Excretion of vacuolating SV-40 virus (Papova Virus Group) after ingestion as a contaminant of oral poliovaccine. Proc Soc Exp Biol. Med. 109, 965-968.
65. Ohgaki, H , Huang, H., Haltia, M., Vainio, H., and Kleihues, P. (2000) More about: Cell and molecular biology of Simian Virus 40: Implications for human infections and disease J Natl. Cancer Inst 92, 495-496.
66. Hirvonen, A., Mattson, K., Karjalainen, A., Ollikainen, T., Tammilehto, L., Hovi, T., Vamio, H., Pass, H. I., Resta I. Di, Carbone, M., and Linnainmaa, K. (1999) Simian virus 40 (SV40)-like DNA sequences not detectable in Finnish mesothelioma patients not exposed to SV40-contaminated polio vaccines. Mol. Carcinog 26, 93-99.
67. Margison, G. P., and Kleihues, P. (1975) Chemical carcinogenesis in the nervous system. Preferential accumulation of O6-methylguanine in rat brain deoxyribonucleic acid during repetitive administration of N-methyl-N- nitrosourea. Biochem. J. 148, 521-525.
68. Goth, R., and Rajewsky, M. F. (1974) Persistence of O6-ethylguanine in rat-brain DNA- correlation with nervous system-specific carcinogenesis by ethylnitrosourea Proc. Natl. Acad Sci. U. S. A 71, 639-643.
69. 6-methylguanine DNA methyltransferase (MGMT) CpG island is associated with heterochromatinization of the MGMT transcription start site and silencing of the gene. Mol. Cell Biol. 17, 5612-5619.
70. 6-methylguanine-DNA methyltransferase gene. Cancer Res 57, 3672-3677.
71. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res. 59, 793-797.
72. Watanabe, T., Nakamura, M , Kros, J M., Burkhard, C., Yonekawa, Y , Kleihues, P , and Ohgaki, H. (2001) Phenotype versus genotype correlation in oligodendrogliomas and low-grade diffuse astrocytomas Acta Neuropathol. 103, 267-275.
73. Ohshima, H , and Bartsch, H. (1994) Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis Mutat. Res. 305, 253-264.
74. Bentivegna, S. S., and Bresnick, E. (1994) Inhibition of human O6-methylguanine-DNA methyltransferase by 5-methylcytosine. Cancer Res 54, 327-329.
75. 6-alkylguanine by alkyltransferases Mutat Res. 462, 83-100.
76. Kleihues, P., and Rajewsky, M F. (1984) Chemical neuro-oncogenesis: role of structural DNA modifications, DNA repair and neural target cell population. Prog Exp. Tumor Res. 27, 1-16.